These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 38659022)

  • 21. Comprehensive Mapping and Dynamics of Site-Specific Prolyl-Hydroxylation, Lysyl-Hydroxylation and Lysyl O-Glycosylation of Collagens Deposited in ECM During Zebrafish Heart Regeneration.
    Sarohi V; Srivastava S; Basak T
    Front Mol Biosci; 2022; 9():892763. PubMed ID: 35782869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycosylation in the tumor immune response: the bitter side of sweetness.
    Cao Y; Yi W; Zhu Q
    Acta Biochim Biophys Sin (Shanghai); 2024 Jun; 56(8):1184-1198. PubMed ID: 38946426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Collagen density regulates the activity of tumor-infiltrating T cells.
    Kuczek DE; Larsen AMH; Thorseth ML; Carretta M; Kalvisa A; Siersbæk MS; Simões AMC; Roslind A; Engelholm LH; Noessner E; Donia M; Svane IM; Straten PT; Grøntved L; Madsen DH
    J Immunother Cancer; 2019 Mar; 7(1):68. PubMed ID: 30867051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of UFMylation in tumorigenesis and cancer immunotherapy.
    Ding LJ; Jiang X; Li T; Wang S
    Front Immunol; 2024; 15():1454823. PubMed ID: 39247188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring Extracellular Matrix Crosslinking as a Therapeutic Approach to Fibrosis.
    Lloyd SM; He Y
    Cells; 2024 Mar; 13(5):. PubMed ID: 38474402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the extracellular matrix for immunomodulation: applications in drug delivery and cell therapies.
    Aghlara-Fotovat S; Nash A; Kim B; Krencik R; Veiseh O
    Drug Deliv Transl Res; 2021 Dec; 11(6):2394-2413. PubMed ID: 34176099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A collagen-binding EGFR single-chain Fv antibody fragment for the targeted cancer therapy.
    Liang H; Li X; Chen B; Wang B; Zhao Y; Zhuang Y; Shen H; Zhang Z; Dai J
    J Control Release; 2015 Jul; 209():101-9. PubMed ID: 25916496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracellular matrix (ECM) stiffness and degradation as cancer drivers.
    Najafi M; Farhood B; Mortezaee K
    J Cell Biochem; 2019 Mar; 120(3):2782-2790. PubMed ID: 30321449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of extracellular matrix proteins by oxidants and electrophiles.
    Yang-Jensen KC; Jørgensen SM; Chuang CY; Davies MJ
    Biochem Soc Trans; 2024 Jun; 52(3):1199-1217. PubMed ID: 38778764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deciphering the "Collagen code" in tumor progression.
    Gupta AA; Kheur S; Palaskar SJ; Narang BR
    J Cancer Res Ther; 2021; 17(1):29-32. PubMed ID: 33723128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compressive Remodeling Alters Fluid Transport Properties of Collagen Networks - Implications for Tumor Growth.
    Ferruzzi J; Sun M; Gkousioudi A; Pilvar A; Roblyer D; Zhang Y; Zaman MH
    Sci Rep; 2019 Nov; 9(1):17151. PubMed ID: 31748563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of extracellular matrix in cancer is associated with enhanced tumor cell targeting by bacteriophage vectors.
    Yata T; Lee EL; Suwan K; Syed N; Asavarut P; Hajitou A
    Mol Cancer; 2015 Jun; 14():110. PubMed ID: 26037383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative proteomic profiling of extracellular matrix and site-specific collagen post-translational modifications in an
    Merl-Pham J; Basak T; Knüppel L; Ramanujam D; Athanason M; Behr J; Engelhardt S; Eickelberg O; Hauck SM; Vanacore R; Staab-Weijnitz CA
    Matrix Biol Plus; 2019 Feb; 1():100005. PubMed ID: 33543004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy.
    Jiang Y; Zhang H; Wang J; Liu Y; Luo T; Hua H
    J Hematol Oncol; 2022 Mar; 15(1):34. PubMed ID: 35331296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insidious changes in stromal matrix fuel cancer progression.
    Miles FL; Sikes RA
    Mol Cancer Res; 2014 Mar; 12(3):297-312. PubMed ID: 24452359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aging and the cardiac collagen matrix: Novel mediators of fibrotic remodelling.
    Horn MA; Trafford AW
    J Mol Cell Cardiol; 2016 Apr; 93():175-85. PubMed ID: 26578393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Collagen XV: exploring its structure and role within the tumor microenvironment.
    Clementz AG; Harris A
    Mol Cancer Res; 2013 Dec; 11(12):1481-6. PubMed ID: 24043668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Collagens in Cancer: Structural Regulators and Guardians of Cancer Progression.
    De Martino D; Bravo-Cordero JJ
    Cancer Res; 2023 May; 83(9):1386-1392. PubMed ID: 36638361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A highly selective humanized DDR1 mAb reverses immune exclusion by disrupting collagen fiber alignment in breast cancer.
    Liu J; Chiang HC; Xiong W; Laurent V; Griffiths SC; Dülfer J; Deng H; Sun X; Yin YW; Li W; Audoly LP; An Z; Schürpf T; Li R; Zhang N
    J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37328286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stiff collagen matrices increase tumorigenic prolactin signaling in breast cancer cells.
    Barcus CE; Keely PJ; Eliceiri KW; Schuler LA
    J Biol Chem; 2013 May; 288(18):12722-32. PubMed ID: 23530035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.